About Triquetra Medicines

Triquetra Medicines is a Swedish pharmaceutical company focused on transforming scientifically and clinically validated therapeutic opportunities into practical healthcare solutions.

Many such opportunities exist. Some are developed through established pharmaceutical pathways. Others remain unrealized despite strong scientific, clinical, and healthcare-system foundations. Triquetra Medicines focuses on these.

A Third Source of Medicines

Modern healthcare relies on two established sources of prescription medicines: innovative branded products and generics. Both are essential. Both create substantial value. But they also define boundaries.

Scientific discoveries, clinical observations, development programs, and healthcare-system needs continuously generate opportunities that do not fit established scientific, commercial, or organizational models. These opportunities remain unaddressed—not because they lack value, but because they do not fit.We describe this space as a third source of medicines. Triquetra Medicines exists to develop from it.

Our Approach

Our opportunities already have strong scientific and clinical foundations. That alone does not create healthcare impact. Impact requires alignment—across development, implementation, pricing, access, manufacturing, and commercialization. We assess opportunities on that basis.

Each is approached as a healthcare-system problem, not a standalone pharmaceutical asset. The objective is to transform it into a viable product, a workable development path, and a sustainable model for delivery and use.

Our Philosophy

Sustainable commercial success follows from maximizing healthcare value—not extracting it. Patient benefit, access, implementation, and long-term commercial performance are not competing objectives. When structured correctly, they reinforce each other.

Our objective is not only to develop products. It is to redesign opportunities so that their full healthcare and commercial potential can be realized.